GMED Globus Medical Inc - Class A

  1. Stocks
  2. Healthcare
  3. NYSE: GMED

Price (delayed)

$74.19

Market cap

$9.96B

P/E Ratio

18.69

Dividend/share

N/A

EPS

$3.97

Enterprise value

$9.56B

?
Relative Growth: Rel. Growth: 97
Relative Strength: Rel. Strength: 37
Relative Valuation: Rel. Valuation: 75
Relative Profitability: Rel. Profitability: 88

Based in Audubon, Pennsylvania, Globus Medical, Inc. was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing ...

Highlights
The P/E is 67% less than the 5-year quarterly average of 57.0 and 7% less than the last 4 quarters average of 20.0
GMED's quick ratio is up by 36% year-on-year
The EPS has surged by 51% year-on-year but it has declined by 9% since the previous quarter
The company's net income has surged by 50% YoY but it fell by 9% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.globusmedical.com
Peers: SYK OFIX ATEC

Key stats

What are the main financial stats of GMED

GMED stock price

How has the Globus Medical stock price performed over time
Intraday
0.86%
1 week
-5.24%
1 month
-12.87%
1 year
24.44%
YTD
-15.03%
QTD
-6.1%

Financial performance

How have Globus Medical's revenue and profit performed over time
Revenue
$3.14B
Gross profit
$2.16B
Operating income
$639.52M
Net income
$535.43M
Gross margin
68.5%
Net margin
17%
The operating income has soared by 127% YoY and by 20% QoQ
The company's operating margin has surged by 90% YoY and by 18% QoQ
The company's net income has surged by 50% YoY but it fell by 9% QoQ
The gross profit has grown by 31% YoY and by 2.5% from the previous quarter

Price vs fundamentals

How does GMED's price correlate with its fundamentals

Growth

What is Globus Medical's growth rate over time

Valuation

What is Globus Medical stock price valuation
GMED P/E details
P/E
18.69
P/B
2.11
P/S
3.19
EV/EBIT
14.88
EV/EBITDA
10.37
EV/Sales
3.04
The P/E is 67% less than the 5-year quarterly average of 57.0 and 7% less than the last 4 quarters average of 20.0
The EPS has surged by 51% year-on-year but it has declined by 9% since the previous quarter
The stock's P/B is 25% less than its 5-year quarterly average of 2.8 and 8% less than its last 4 quarters average of 2.3
GMED's equity is up by 11% year-on-year
GMED's P/S is 36% lower than its 5-year quarterly average of 5.0 and 9% lower than its last 4 quarters average of 3.5
Globus Medical's revenue has increased by 20% YoY

Efficiency

How efficient is Globus Medical business performance
GMED's ROIC is up by 46% year-on-year but it is down by 3.8% since the previous quarter
The return on sales has grown by 45% year-on-year but it has declined by 2.4% since the previous quarter
The ROA is up by 41% year-on-year but it is down by 12% since the previous quarter
Globus Medical's return on equity has increased by 35% YoY but it has decreased by 11% QoQ

Dividends

What is GMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GMED.

Financial health

How did Globus Medical financials performed over time
GMED's quick ratio is up by 36% year-on-year
Globus Medical's current ratio has increased by 14% YoY
The debt is 98% smaller than the equity
The company's debt to equity fell by 33% YoY
GMED's equity is up by 11% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.